Inventor · disambiguated record
Anil Panmand
Also filed as: PANMAND ANIL
8 granted patents·1 pending application·32 citations·filing 2009–2022
80Inventor score
Files withBARAWKAR DINESH2IMPETIS BIOSCIENCES LTD2PALLE VENKATA2TAKEDA PHARMACEUTICALS CO2ADVINUS THERAPEUTICS PRIVATE LTD1
Top patents by PatentIndex Score
9 records- 0189US8859566B2Substituted fused pyrimidine compoundsPALLE VENKATA·Filed 2010·Granted Oct 14, 2014·26 cites·13 claims
- 0272US8252797B2Heterocyclic compounds as adenosine receptor antagonistPALLE VENKATA·Filed 2009·Granted Aug 28, 2012·2 cites·12 claims
- 0369US8940751B2Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applicationsBARAWKAR DINESH·Filed 2011·Granted Jan 27, 2015·2 cites·5 claims
- 0467US11407758B2Tricyclic compounds, compositions and medicinal applications thereofIMPETIS BIOSCIENCES LTD·Filed 2019·Granted Aug 9, 2022·1 cites·12 claims
- 0563US11981679B2Tricyclic compounds, compositions and medicinal applications thereofIMPETIS BIOSCIENCES LTD·Filed 2022·Granted May 14, 2024·0 cites·12 claims
- 0663US9284316B2Substituted fused pyrimidine compoundsADVINUS THERAPEUTICS PRIVATE LTD·Filed 2014·Granted Mar 15, 2016·1 cites·13 claims
- 0757US2020339577A11-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as ep4 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 0844US10745397B21-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Aug 18, 2020·0 cites·5 claims
- 0932US9006177B2Fused tricyclic compounds as adenosine receptor antagonistBARAWKAR DINESH·Filed 2011·Granted Apr 14, 2015·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Anil Panmand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →